| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals.
|
2016
|
0.93
|
|
2
|
Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.
|
2015
|
0.90
|
|
3
|
Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution.
|
2014
|
0.90
|
|
4
|
Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics.
|
2013
|
0.87
|
|
5
|
Livestock-Associated MRSA: The Impact on Humans.
|
2015
|
0.86
|
|
6
|
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.
|
2015
|
0.86
|
|
7
|
Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients.
|
2014
|
0.86
|
|
8
|
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance.
|
2013
|
0.85
|
|
9
|
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.
|
2015
|
0.85
|
|
10
|
Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials.
|
2016
|
0.84
|
|
11
|
Ureteral Stents and Foley Catheters-Associated Urinary Tract Infections: The Role of Coatings and Materials in Infection Prevention.
|
2014
|
0.83
|
|
12
|
Colonization Resistance of the Gut Microbiota against Clostridium difficile.
|
2015
|
0.82
|
|
13
|
Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.
|
2014
|
0.82
|
|
14
|
Foreign Body Infection Models to Study Host-Pathogen Response and Antimicrobial Tolerance of Bacterial Biofilm.
|
2014
|
0.82
|
|
15
|
Public Beliefs about Antibiotics, Infection and Resistance: A Qualitative Study.
|
2013
|
0.81
|
|
16
|
Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.
|
2015
|
0.81
|
|
17
|
The Membrane Steps of Bacterial Cell Wall Synthesis as Antibiotic Targets.
|
2016
|
0.80
|
|
18
|
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
|
2014
|
0.80
|
|
19
|
Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins.
|
2016
|
0.80
|
|
20
|
Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia.
|
2013
|
0.80
|
|
21
|
Antimicrobial Stewardship and Urinary Tract Infections.
|
2014
|
0.80
|
|
22
|
Phenotypic Resistance to Antibiotics.
|
2013
|
0.80
|
|
23
|
Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes.
|
2014
|
0.80
|
|
24
|
Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.
|
2014
|
0.80
|
|
25
|
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials.
|
2016
|
0.79
|
|
26
|
Analysis of Tetracyclines in Medicated Feed for Food Animal Production by HPLC-MS/MS.
|
2015
|
0.79
|
|
27
|
Patient Attitudes and Beliefs and Provider Practices Regarding Antibiotic Use for Acute Respiratory Tract Infections in Minya, Egypt.
|
2014
|
0.79
|
|
28
|
Environmental and Public Health Implications of Water Reuse: Antibiotics, Antibiotic Resistant Bacteria, and Antibiotic Resistance Genes.
|
2013
|
0.79
|
|
29
|
Biotin Protein Ligase Is a Target for New Antibacterials.
|
2016
|
0.79
|
|
30
|
Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.
|
2013
|
0.78
|
|
31
|
A Clinical Drug Library Screen Identifies Tosufloxacin as Being Highly Active against Staphylococcus aureus Persisters.
|
2015
|
0.78
|
|
32
|
A Review of Management of Clostridium difficile Infection: Primary and Recurrence.
|
2015
|
0.78
|
|
33
|
Reconsultation and Antimicrobial Treatment of Urinary Tract Infection in Male and Female Patients in General Practice.
|
2016
|
0.78
|
|
34
|
Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection.
|
2015
|
0.78
|
|
35
|
Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance.
|
2013
|
0.78
|
|
36
|
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease.
|
2014
|
0.78
|
|
37
|
Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms.
|
2014
|
0.78
|
|
38
|
Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library.
|
2015
|
0.78
|
|
39
|
Antimicrobial Usage and Antimicrobial Resistance in Animal Production in Southeast Asia: A Review.
|
2016
|
0.78
|
|
40
|
An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA).
|
2015
|
0.78
|
|
41
|
Genomic, Transcriptomic and Metabolomic Studies of Two Well-Characterized, Laboratory-Derived Vancomycin-Intermediate Staphylococcus aureus Strains Derived from the Same Parent Strain.
|
2015
|
0.77
|
|
42
|
Core Steps of Membrane-Bound Peptidoglycan Biosynthesis: Recent Advances, Insight and Opportunities.
|
2015
|
0.77
|
|
43
|
Going beyond the Control of Quorum-Sensing to Combat Biofilm Infections.
|
2016
|
0.77
|
|
44
|
Exploratory Spatial Mapping of the Occurrence of Antimicrobial Resistance in E. coli in the Community.
|
2013
|
0.77
|
|
45
|
NETs and CF Lung Disease: Current Status and Future Prospects.
|
2015
|
0.77
|
|
46
|
Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in Virulence.
|
2013
|
0.77
|
|
47
|
In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.
|
2014
|
0.77
|
|
48
|
Acquired Class D β-Lactamases.
|
2014
|
0.77
|
|
49
|
Old and New Glycopeptide Antibiotics: Action and Resistance.
|
2014
|
0.77
|
|
50
|
Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens.
|
2015
|
0.77
|